BRIDGETTE HULL: Open Payments
NPI 1487280483 · WICHITA, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$973 in 49 payments from 11 companies in 2025. Trend: 2023 $1,693 · 2024 $2,274 · 2025 $973
Food & beverage: $973
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 16 | $216 |
| Amgen Inc. | 7 | $138 |
| GENZYME CORPORATION | 4 | $127 |
| PFIZER INC. | 1 | $111 |
| E.R. Squibb & Sons, L.L.C. | 5 | $94 |
| Lilly USA, LLC | 4 | $81 |
| Novartis Pharmaceuticals Corporation | 4 | $64 |
| UCB, Inc. | 3 | $57 |
| Janssen Biotech, Inc. | 2 | $39 |
| Galderma Laboratories, L.P. | 2 | $32 |
Products named: SKYRIZI, OTEZLA, DUPIXENT, LITFULO, Sotyktu, Bimzelx, TALTZ, COSENTYX.
Industry payments across KS — which companies pay providers there.
